Journal for ImmunoTherapy of Cancer (Nov 2021)
304 Antagonistic antibodies targeting LAIR1 enhance T lymphocyte activation and promote inflammatory phenotypes in myeloid cells
- Tao Huang,
- An Song,
- Ryan Stafford,
- Maria Jose Costa,
- Jing-Tyan Ma,
- Krista McCutcheon,
- Heyu Chen,
- Kyu Hong,
- Ningyan Zhang,
- Zhiqiang An,
- Cheng Cheng Zhang,
- X Charlene Liao,
- Caroline Bonnans,
- Azita Tabrizi,
- Jingjing Xie,
- Hongyu Tian,
- Xun Gui
Affiliations
- Tao Huang
- Department of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China
- An Song
- 1Immune-Onc Therapeutics, Palo Alto, CA, USA
- Ryan Stafford
- 1Immune-Onc Therapeutics, Palo Alto, CA, USA
- Maria Jose Costa
- 1Immune-Onc Therapeutics, Palo Alto, CA, USA
- Jing-Tyan Ma
- 1Immune-Onc Therapeutics, Palo Alto, CA, USA
- Krista McCutcheon
- 1Immune-Onc Therapeutics, Palo Alto, CA, USA
- Heyu Chen
- 3University of Texas Southwestern, Dallas, TX, USA
- Kyu Hong
- 1Immune-Onc Therapeutics, Palo Alto, CA, USA
- Ningyan Zhang
- 2University of Texas Health Science Center, Houston, TX, USA
- Zhiqiang An
- 2University of Texas Health Science Center, Houston, TX, USA
- Cheng Cheng Zhang
- 3University of Texas Southwestern, Dallas, TX, USA
- X Charlene Liao
- 1Immune-Onc Therapeutics, Palo Alto, CA, USA
- Caroline Bonnans
- 1Immune-Onc Therapeutics, Inc., Palo Alto, CA, USA
- Azita Tabrizi
- 1Immune-Onc Therapeutics, Inc., Palo Alto, CA, USA
- Jingjing Xie
- 2UT Southwestern Medical Center, Dallas, TX, USA
- Hongyu Tian
- 1Immune-Onc Therapeutics, Inc., Palo Alto, CA, USA
- Xun Gui
- 3UT Health Science Center, Houston, TX, USA
- DOI
- https://doi.org/10.1136/jitc-2021-SITC2021.304
- Journal volume & issue
-
Vol. 9,
no. Suppl 2
Abstract
No abstracts available.
